-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

322.P1.37 322. Hemophilia A and B: Clinical and Epidemiological: Poster I

Symposia: Hemophilia A and B: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Saturday, December 7, 2024: 5:30 PM-7:30 PM
Halls G-H (San Diego Convention Center)

Fernando F Corrales-Medina, MD1, Nana Ama Afari-Dwamena, MPH2*, Amanda B. Blair, MD3, Shannon L Carpenter4, Tammuella Chrisentery-Singleton, MD5, Nabil Daoud, MA2*, Maissaa Janbain, MD6, Leslie Raffini, MD7, Jonathan Schwartz, MS2*, Ayesha Zia, MD, MSc8 and Michael Recht, MD, PhD, MBA9,10

1Division of Pediatric Hematology-Oncology, University of Miami-Miller School of Medicine-Sylvester Cancer Center, Miami, FL
2American Thrombosis and Hemostasis Network, Cornwall, NY
3Pediatrics, Atrium Health Wake Forest Baptist, Winston-Salem, NC
4Children's Mercy Hospital, Kansas City, MO
5American Thrombosis and Hemostasis Network, New Orleans, LA
6Department of Hematology and Oncology, Tulane University School of Medicine, New Orleans, LA
7Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, PA
8Dept. of Pediatrics; Division of Hematology-Oncology, UT Southwestern Medical Center, Dallas, TX
9Yale Center for Bleeding and Clotting Disorders, Yale University School of Medicine, New Haven, CT
10National Bleeding Disorders Foundation, New York, NY

Cedric Hermans, MD, MRCP, PhD1,2,3, Catherine Lambert, MD, PhD4*, Sébastien Lobet, PhD5* and Evelien Krumb, MD6*

1Cliniques Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
2Cliniques universitaires Saint-Luc, Cedric Hermans, Brussels, Belgium
3Cliniques Universitaires Saint-Luc, Brussels, BEL
4Cliniques universitaires Saint-Luc, Université catholique de Louvain, Bruxelles, BEL
5Division of Hematology, Cliniques universitaires Saint-Luc, Bruxelles, Belgium
6Cliniques universitaires Saint-Luc, Université catholique de Louvain, Brussels, Belgium

Prashant Raghavendran, DO1, Robert F Sidonio Jr., MD2* and Glaivy Batsuli, MD3

1AFLAC Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
2Emory University School of Medicine, Atlanta, GA
3Stanford University, Stanford, CA

Tripti Jain, MD1*, Sangam Sangam, MD2, Marco Bermudez, MD2* and Shorabh Sharma, MD2*

1Rochester General Hospital, Rochester, NY
2Department of Medicine, SBH Health System, Bronx, NY

Anne de Vaan, MD1*, Marieke JHA Kruip, MD, PhD2*, Jeroen Eikenboom, MD, PhD3, Elke A Doeff1*, Marieke C Punt, MD, PhD1*, Michiel Coppens, MD, PhD4*, Laurens Nieuwenhuizen, MD PhD5*, Saskia EM Schols, MD, PhD6*, Anja BU Mäkelburg, MD, PhD7*, Floor CJI Moenen, MD, PhD8*, Hans JJ Duvekot, Md, PhD9*, Annemieke JM Middeldorp, MD, PhD10*, Kitty WM Bloemenkamp, MD, PhD11*, Roger EG Schutgens, MD, PhD, MSc1* and Karin PM van Galen, MD, PhD1*

1Center for Benign Hematology, Thrombosis and Hemostasis - Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
2Department of Hematology, Erasmus MC, Erasmus University Medical Center Rotterdam, Rotterdam, NLD
3Department of Internal Medicine, Division of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, Netherlands
4Amsterdam University Medical Centers, Department of Vascular Medicine, University of Amsterdam and Amsterdam Cardiovascular Sciences, Pulmonary Hypertension & Thrombosis, Amsterdam, Netherlands
5Department of Internal Medicine, Máxima Medisch Centrum, Eindhoven, Netherlands
6Department of Hematology, Radboud University Medical Center, Nijmegen, Netherlands
7Department of Hematology, University Medical Center Groningen, Groningen, Netherlands
8Department of Internal Medicine, Hematology, Maastricht University Medical Center+ and Hemophilia Treatment Center Nijmegen-Eindhoven-Maastricht, Maastricht, Netherlands
9Department of Gynaecology and Obstetrics, Erasmus MC, Erasmus University Medical Center, Rotterdam, Rotterdam, Netherlands
10Department of Obstetrics, Leiden University Medical Center, Leiden, Netherlands
11Department of Woman and Baby, University Medical Center Utrecht, Wilhelmina Children's Hospital, Utrecht, Netherlands

Priyanka Pechetty1, Chandrakala Shanmukhaiah, MD, MBBS2*, Shubhranshu Shekhar Mohanty3*, Shwetal Ghule Pawar4*, Kirti Amol Patil4* and Dileep Y5*

1Dr J C Patel Department of Clinical Hematology, King Edward Memorial Hospital & Seth G S Medical College, Mumbai, India
2Dr J C Patel Department of Clinical Hematology, KING EDWARD MEMORIAL HOSPITAL SETH GORDHANDAS SUNDERDAS MEDICAL COLLEGE, Mumbai, Maharashtra, IND
3Department of Orthopedics, KING EDWARD MEMORIAL HOSPITAL SETH GORDHANDAS SUNDERDAS MEDICAL COLLEGE, Mumbai, India
4Seth GS Medical College and K.E.M Hospital, Mumbai, India
5Seth GS Medical College & KEM Hospital, Mumbai, India

Carrie Turich Taylor, PhD, MHS1*, Eunhee Hwang, PhD2*, Tina Hinnershitz, BS1*, Eugeny Mefyod, MD3*, Sangeeta V Raje, PhD2*, John Teeter, MD1*, Travis Gould, PhD4 and Andrew Palladino, MD5*

1Pfizer Inc, Groton, CT
2Pfizer Inc, Collegeville, PA
3Pfizer Inc, Walton Oaks, United Kingdom
4Pfizer Inc, New York, NY
5Global Clinical Lead for the Marstacimab Program at Pfizer, Pfizer Inc, Collegeville, PA

Keiji Nogami1*, Teruhisa Fujii2*, Akihiro Sawada3*, Azusa Nagao4*, Chiai Nagae5*, Masanori Nojima6*, Nobuaki Suzuki7*, Mika Kawano8*, Tomomi Shimura8*, Yoshimasa Sugao8* and Kagehiro Amano9

1Nara Medical University, Nara, Japan
2Division of Transfusion Medicine/Hemophilia Treatment Center, Hiroshima University Hospital, Hiroshima, HIR, JPN
3Department of Respiratory Medicine and Hematology, Hyogo College of Medicine, Hyogo, Japan
4Department of Blood Coagulation, Ogikubo Hospital, Tokyo, Japan
5Department of Pediatrics, St Marianna University School of Medicine, Kanagawa, Japan
6Center for Translational Research, The Institute of Medical Science Hospital, The University of Tokyo, Tokyo, Japan
7Department of Transfusion Medicine, Nagoya University Hospital, Aichi, Japan
8Chugai Pharmaceutical Co., Ltd., Tokyo, Japan
9Department of Laboratory Medicine, Tokyo Medical University, Tokyo, JPN

Cedric Hermans, MD, MRCP, PhD1, Cihan Ay2*, Carmen Escuriola, MD3*, Peter Kampmann, MD4*, Rikke Medom Meldgaard5*, Ilgiz Rakhmatullin5*, Ciprian Tomuleasa, MD6*, Lize Fie Ditteke van Vulpen, MD, PhD7*, Michael Wang, MD8*, Irena Woźnica-Karczmarz, MD9* and Sophie Susen, MD, PhD10*

1Division of Hematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium
2Division of Hematology and Hemostaseology, Department of Medicine, Medical University of Vienna, Vienna, Austria
3Haemophilie-Zentrum Rhein Main, HZRM, Frankfurt, Germany
4Rigshospitalet, Copenhagen, Denmark
5Novo Nordisk A/S, Søborg, Denmark
6Department of Haematology – Medfuture Research Center, Iuliu Hatieganu University of Medicine and Pharmacy, Ion Chiricuta Institute of Oncology, Cluj-Napoca, Romania
7Center for Benign Haematology, Thrombosis and Haemostasis, Van Creveldkliniek, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands
8University of Colorado Hemophilia and Thrombosis Center, Aurora, CO
9Department of Transfusion Medicine, Children’s University Hospital, Lublin, Poland
10Hemostasis and Transfusion Department, University of Lille, Lille University Hospital, Lille, France

Wei Liu, MD1*, Hu Zhou2, Ruibin Huang, MD3*, Xin Du4*, ZePing Zhou, MD, PhD5, Changcheng Zheng, MD6*, Shifeng Lou, MD7*, Xinyue Dai, MD1*, Renchi Yang, MD1 and Lei Zhang1

1Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Department of Hematology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
3The First Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China
4Department of Hematology, The Second People's Hospital of Shenzhen, The First Affiliated Hospital of Shenzhen University, Shenzhen, China
5Second Affiliated Hospital of Kunming Medical University, Kunming, China
6Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, China
7The second affiliated hospital of Chongqing Medical University, Chongqing, China

Shannon L Carpenter1, Dakota Rosenfelt2*, Eunice Tzeng2*, Elise Lim2* and Steven W. Pipe, MD3

1Children's Mercy Hospital, Kansas City, MO
2Genentech, Inc., South San Francisco, CA
3University of Michigan, Ann Arbor, MI

Satyaprakash Nayak, PhD1*, Akiyuki Suzuki, PhD2*, Patanjali Ravva, PhD3* and Sangeeta V Raje, PhD3*

1Pfizer Inc, Cambridge, MA
2Pfizer R&D Japan, Tokyo, Japan
3Pfizer Inc, Collegeville, PA

*signifies non-member of ASH